|
|
Sign up for our e-newsletter to get headline health news and advanced information on new courses and conferences. |
|
Go Back
|
|
Type 2 Diabetes and Cardiovascular Disease: Decreasing the Risk |
 |
| SKU: |
NCME339 |
Format: |
Webcast |
Cost: |
Free |
| Credits: |
1.50 AMA PRA Category I Credit(s) ™
1.50 AANP Contact hour(s) |
|
Making Sense of Evolving Data to Lower CV Risk: Integrating PCSK9 Therapy into Practice |
|
| SKU: |
NCME340 |
Format: |
Webcast |
Cost: |
Free |
| Credits: |
1.0 AMA PRA Category I Credit(s) ™
1.0 AANP Contact hour(s) |
|
Confronting Psoriatic Disease: Putting New Tools to Work |
|
| SKU: |
NCME348 |
Format: |
Webcast |
Cost: |
Free |
| Credits: |
1.0 AMA PRA Category I Credit(s) ™
1.0 AANP Contact hour(s) which includes 0.75 pharmacology hour(s) |
|
The Evolving Paradigm in Atopic Dermatitis: Integrating Evolving Treatments to Improve Outcomes |
|
| SKU: |
NCME352 |
Format: |
Webcast |
Cost: |
Free |
| Credits: |
1.0 AMA PRA Category I Credit(s) ™
1.0 AANP Contact hour(s) which includes 0.75 pharmacology hour(s) |
|
Atopic Dermatitis: New Insights, New Therapies |
|
| SKU: |
NCME353 |
Format: |
Webcast |
Cost: |
Free |
| Credits: |
1.0 AMA PRA Category I Credit(s) ™
1.0 AANP Contact hour(s) which includes .75 pharmacology hour(s) |
|
The Progression of Type 2 Diabetes: A Rational Approach for Long-term Disease Management |
|
| SKU: |
NCME355 |
Format: |
Webcast |
Cost: |
Free |
| Credits: |
1.0 AMA PRA Category I Credit(s) ™
1.0 AANP Contact hour(s) which includes 0.75 pharmacology hour(s) |
|
Safely Achieving Goals in Type 2 Diabetes (T2D): The Role of Concentrated and Long-Acting Insulins |
|
| SKU: |
NCME356 |
Format: |
Webcast |
Cost: |
Free |
| Credits: |
1.0 AMA PRA Category I Credit(s) ™
1.0 AANP Contact hour(s) which includes 0.75 pharmacology hour(s) |
|
The Evolving Landscape of COPD: Strategies to Optimize Care and Improve Outcomes |
|
| SKU: |
NCME344 |
Format: |
Webcast |
Cost: |
Free |
| Credits: |
1.0 AMA PRA Category I Credit(s) ™
1.0 AANP Contact hour(s) which includes .75 pharmacology hour(s) |
|
Emerging Trends in Evaluation and Management of Postmenopausal Osteoporosis |
|
| SKU: |
NCME347 |
Format: |
Webcast |
Cost: |
Free |
| Credits: |
1.0 AMA PRA Category I Credit(s) ™
1.0 AANP Contact hour(s) which includes 0.75 pharmacology hour(s) |
|
Pseudobulbar Affect: A Call to Action |
|
| SKU: |
NCME337 |
Format: |
Webcast |
Cost: |
Free |
| Credits: |
1.25 AMA PRA Category I Credit(s) ™
1.25 AANP Contact hour(s) which includes .25 pharmacology hour(s) |
|
Diagnosis and Treatment of the Alpha-1 Antitrypsin Deficiency: A Genetic Subgroup of COPD |
|
| SKU: |
NCME349 |
Format: |
Webcast |
Cost: |
Free |
| Credits: |
1.0 AMA PRA Category I Credit(s) ™
1.0 AANP Contact hour(s) |
|
A Stepwise Approach to Analyzing Pulmonary Functions: ABG, PFT, and Spirometry |
|
| SKU: |
NCME335 |
Format: |
Webcast |
Cost: |
$79.00 |
| Credits: |
4.0 AMA PRA Category I Credit(s) ™
4.0 AANP Contact hour(s) |
|
Idiopathic Pulmonary Fibrosis (IPF): Defining the Role of the Primary Care Clinician in Diagnosis and Therapy |
|
| SKU: |
NCME338 |
Format: |
Webcast |
Cost: |
Free |
| Credits: |
1.25 AMA PRA Category I Credit(s) ™
1.25 AANP Contact hour(s) which includes .25 pharmacology hour(s) |
|
Pulmonary Arterial Hypertension and Combination Therapy: Recognizing the Role, Timing and Strategy for Advancing Care |
|
| SKU: |
NCME351 |
Format: |
Webcast |
Cost: |
Free |
| Credits: |
1.0 AMA PRA Category I Credit(s) ™
1.0 AANP Contact hour(s) |
|
The Evolution of IPF Diagnosis and Management: Incorporating New Data into Practice |
|
| SKU: |
NCME350 |
Format: |
Webcast |
Cost: |
Free |
| Credits: |
1.0 AMA PRA Category I Credit(s) ™
1.0 AANP Contact hour(s) |
|
The Role of Type 2 Inflammation in Severe Asthma: Integrating Biologic Therapy to Optimize Outcomes |
|
| SKU: |
NCME354 |
Format: |
Webcast |
Cost: |
Free |
| Credits: |
1.0 AMA PRA Category I Credit(s) ™
1.0 AANP Contact hour(s) which includes 0.25 pharmacology hour(s) |
|
|
